Precigen Stock Revenue
| PGEN Stock | USD 1.76 0.09 5.39% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Precigen's long-term financial health and intrinsic value.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 3.9 M | 3.7 M |
Precigen | Revenue | Build AI portfolio with Precigen Stock |
Precigen Company Revenue Analysis
Precigen's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Precigen Revenue | 3.92 M |
Most of Precigen's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Precigen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Precigen
Projected quarterly revenue analysis of Precigen provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Precigen match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Precigen's stock price.
Precigen Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for Precigen is extremely important. It helps to project a fair market value of Precigen Stock properly, considering its historical fundamentals such as Revenue. Since Precigen's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Precigen's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Precigen's interrelated accounts and indicators.
| 0.85 | 0.42 | -0.42 | 0.58 | 0.44 | ||
| 0.85 | 0.53 | -0.56 | 0.44 | 0.58 | ||
| 0.42 | 0.53 | -0.33 | 0.77 | 0.64 | ||
| -0.42 | -0.56 | -0.33 | -0.2 | -0.88 | ||
| 0.58 | 0.44 | 0.77 | -0.2 | 0.47 | ||
| 0.44 | 0.58 | 0.64 | -0.88 | 0.47 |
Click cells to compare fundamentals
Precigen Revenue Historical Pattern
Today, most investors in Precigen Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Precigen's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Precigen revenue as a starting point in their analysis.
Precigen Revenue |
| Timeline |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Precigen Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Precigen reported 3.92 M of revenue. This is 99.95% lower than that of the Biotechnology sector and 99.47% lower than that of the Health Care industry. The revenue for all United States stocks is 99.96% higher than that of the company.
Precigen Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Precigen's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Precigen could also be used in its relative valuation, which is a method of valuing Precigen by comparing valuation metrics of similar companies.Precigen is currently under evaluation in revenue category among its peers.
Precigen Current Valuation Drivers
We derive many important indicators used in calculating different scores of Precigen from analyzing Precigen's financial statements. These drivers represent accounts that assess Precigen's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Precigen's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 844.7M | 1.7B | 304.5M | 327.7M | 376.8M | 358.0M | |
| Enterprise Value | 1.0B | 1.8B | 351.1M | 327.2M | 376.3M | 357.5M |
Precigen Institutional Holders
Institutional Holdings refers to the ownership stake in Precigen that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Precigen's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Precigen's value.| Shares | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 1 M | Jpmorgan Chase & Co | 2025-03-31 | 813.3 K | Renaissance Technologies Corp | 2025-03-31 | 792.8 K | Ci Private Wealth Llc | 2025-03-31 | 714.7 K | Lexaurum Advisors, Llc | 2025-06-30 | 672.5 K | Gmt Capital Corp | 2025-03-31 | 668.8 K | Ubs Group Ag | 2025-03-31 | 512.3 K | Fore Capital, Llc | 2025-03-31 | 391.8 K | Goldman Sachs Group Inc | 2025-03-31 | 333.5 K | Patients Capital Management Llc | 2025-03-31 | 17.4 M | Adage Capital Partners Gp Llc | 2025-03-31 | 11.3 M |
Precigen Fundamentals
| Return On Equity | -2.79 | ||||
| Return On Asset | -0.44 | ||||
| Operating Margin | (16.85) % | ||||
| Current Valuation | 421.08 M | ||||
| Shares Outstanding | 295.18 M | ||||
| Shares Owned By Insiders | 10.56 % | ||||
| Shares Owned By Institutions | 67.08 % | ||||
| Number Of Shares Shorted | 28.43 M | ||||
| Price To Earning | (2.06) X | ||||
| Price To Book | 7.25 X | ||||
| Price To Sales | 117.34 X | ||||
| Revenue | 3.92 M | ||||
| Gross Profit | (53.16 M) | ||||
| EBITDA | (123.5 M) | ||||
| Net Income | (126.23 M) | ||||
| Cash And Equivalents | 115.3 M | ||||
| Cash Per Share | 0.55 X | ||||
| Total Debt | 5.5 M | ||||
| Debt To Equity | 3.73 % | ||||
| Current Ratio | 5.51 X | ||||
| Book Value Per Share | (0.05) X | ||||
| Cash Flow From Operations | (68.17 M) | ||||
| Short Ratio | 12.18 X | ||||
| Earnings Per Share | (0.55) X | ||||
| Price To Earnings To Growth | (1.52) X | ||||
| Target Price | 6.0 | ||||
| Number Of Employees | 143 | ||||
| Beta | 1.78 | ||||
| Market Capitalization | 492.95 M | ||||
| Total Asset | 145.27 M | ||||
| Retained Earnings | (2.09 B) | ||||
| Working Capital | 80.9 M | ||||
| Current Asset | 285.72 M | ||||
| Current Liabilities | 66.91 M | ||||
| Net Asset | 145.27 M |
About Precigen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Precigen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Precigen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Precigen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Precigen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Precigen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Precigen will appreciate offsetting losses from the drop in the long position's value.Moving against Precigen Stock
| 0.55 | VCEL | Vericel Corp Ord | PairCorr |
| 0.47 | VCYT | Veracyte Earnings Call This Week | PairCorr |
| 0.36 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.32 | DRMA | Dermata Therapeutics | PairCorr |
| 0.31 | DWTX | Dogwood Therapeutics, Symbol Change | PairCorr |
The ability to find closely correlated positions to Precigen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Precigen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Precigen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Precigen to buy it.
The correlation of Precigen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Precigen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Precigen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Precigen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Precigen Piotroski F Score and Precigen Altman Z Score analysis. To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precigen. If investors know Precigen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precigen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.55) | Revenue Per Share | Quarterly Revenue Growth 0.259 | Return On Assets | Return On Equity |
The market value of Precigen is measured differently than its book value, which is the value of Precigen that is recorded on the company's balance sheet. Investors also form their own opinion of Precigen's value that differs from its market value or its book value, called intrinsic value, which is Precigen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precigen's market value can be influenced by many factors that don't directly affect Precigen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precigen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Precigen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precigen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.